# Unicycive Therapeutics, Inc.: Form 8-K, filed Jul 15, 2024

- Company: [Unicycive Therapeutics, Inc.](/companies/uncy.md) (CIK 1766140)
- Form: 8-K
- Filed: 2024-07-15
- Accepted by EDGAR: Jul 15, 2024, 16:15 ET
- Period: 2024-07-09
- Accession: 0001213900-24-061355
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024061355/ea0209297-8k_unicycive.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1766140/000121390024061355/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1766140/000121390024061355/ea0209297-8k_unicycive.htm

Filed Jul 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-061355. Last ingested by Listed: Oct 29, 2026, 16:30 ET. No prices; not investment advice.